MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new, clinically validated genetic ...

HUNTSVILLE, Ala. (WHNT) — Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime. However, chances of survival are good when it’s caught early.

Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...

Prostate cancer screenings slash the risk of dying from the disease in the following decades, according to new research. The screening measures the amount of prostate-specific antigen (PSA) in men’s ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

For men, a new urine test is improving prostate cancer detection. Men know about the PSA test but there's another test, the "mi-prostate score" or MIPS. It's been available since 2013. It combines PSA ...

A leading professor who specialises in the research of prostate cancer has revealed the one thing all men should know and ask ...